Research has been conducted on the CoronaVac vaccine in children and adolescents, with studies examining its efficacy, immunogenicity, and safety in this age group. The vaccine has been found to be safe and induce immunity in healthy children and adolescents in various trials. However, the specific outcomes and details of these studies, including the age range and trial designs, appear to vary across different reports.